89 related articles for article (PubMed ID: 17498077)
1. Upper gastrointestinal bleeding in haemophiliacs: incidence and relation to use of non-steroidal anti-inflammatory drugs.
Eyster ME; Asaad SM; Gold BD; Cohn SE; Goedert JJ;
Haemophilia; 2007 May; 13(3):279-86. PubMed ID: 17498077
[TBL] [Abstract][Full Text] [Related]
2. Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs.
Papatheodoridis GV; Papadelli D; Cholongitas E; Vassilopoulos D; Mentis A; Hadziyannis SJ
Am J Med; 2004 May; 116(9):601-5. PubMed ID: 15093756
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
[TBL] [Abstract][Full Text] [Related]
5. Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases.
van Soest EM; Valkhoff VE; Mazzaglia G; Schade R; Molokhia M; Goldstein JL; Hernández-Díaz S; Trifirò G; Dieleman JP; Kuipers EJ; Sturkenboom MC
Gut; 2011 Dec; 60(12):1650-9. PubMed ID: 21636644
[TBL] [Abstract][Full Text] [Related]
6. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers.
Wong GL; Wong VW; Chan Y; Ching JY; Au K; Hui AJ; Lai LH; Chow DK; Siu DK; Lui YN; Wu JC; To KF; Hung LC; Chan HL; Sung JJ; Chan FK
Gastroenterology; 2009 Aug; 137(2):525-31. PubMed ID: 19445937
[TBL] [Abstract][Full Text] [Related]
7. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S
Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481
[TBL] [Abstract][Full Text] [Related]
8. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding.
Carson JL; Strom BL; Soper KA; West SL; Morse ML
Arch Intern Med; 1987 Jan; 147(1):85-8. PubMed ID: 3492182
[TBL] [Abstract][Full Text] [Related]
9. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study.
Nørgård B; Pedersen L; Johnsen SP; Tarone RE; McLaughlin JK; Friis S; Sørensen HT
Aliment Pharmacol Ther; 2004 Apr; 19(7):817-25. PubMed ID: 15043523
[TBL] [Abstract][Full Text] [Related]
10. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents.
Laporte JR; Ibáñez L; Vidal X; Vendrell L; Leone R
Drug Saf; 2004; 27(6):411-20. PubMed ID: 15144234
[TBL] [Abstract][Full Text] [Related]
11. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
al-Assi MT; Genta RM; Karttunen TJ; Graham DY
Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
[TBL] [Abstract][Full Text] [Related]
12. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.
Hippisley-Cox J; Coupland C; Logan R
BMJ; 2005 Dec; 331(7528):1310-6. PubMed ID: 16322018
[TBL] [Abstract][Full Text] [Related]
13. More favorable outcomes with peptic ulcer bleeding due to Helicobacter pylori.
Chason RD; Reisch JS; Rockey DC
Am J Med; 2013 Sep; 126(9):811-818.e1. PubMed ID: 23830535
[TBL] [Abstract][Full Text] [Related]
14. Comparative incidence of upper gastrointestinal bleeding associated with individual non-steroidal anti-inflammatory drugs.
Llorente Melero MJ; Tenías Burillo JM; Zaragoza Marcet A
Rev Esp Enferm Dig; 2002 Jan; 94(1):7-18. PubMed ID: 12073673
[TBL] [Abstract][Full Text] [Related]
15. Incidence and etiology of acute non-malignant upper gastrointestinal bleeding in northern Greece.
Tsesmeli NE; Kotsaftis PS; Savopoulos CG; Hatzitolios AI; Kaiafa GD; Kounanis AD; Karamitsos DT
J Gastroenterol Hepatol; 2007 Jul; 22(7):1009-13. PubMed ID: 17608846
[TBL] [Abstract][Full Text] [Related]
16. Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study.
Etminan M; Lévesque L; Fitzgerald JM; Brophy JM
Aliment Pharmacol Ther; 2009 Jun; 29(11):1188-92. PubMed ID: 19298582
[TBL] [Abstract][Full Text] [Related]
17. Acute upper gastrointestinal bleeding in Jerusalem 1988-91: causes, characteristics and relation to nonsteroidal anti-inflammatory drugs.
Zimmerman J; Arnon R; Ligumski M; Beeri R; Keret D; Lysy J; Fich A; Tsvang E; Siguencia J; Gonzalez J
Isr J Med Sci; 1993 May; 29(5):292-7. PubMed ID: 8314690
[TBL] [Abstract][Full Text] [Related]
18. Acute upper gastrointestinal bleeding: comparison between recent users and nonusers of nonsteroidal anti-inflammatory drugs.
Adamopoulos A; Efstathiou S; Tsioulos D; Tsami A; Mitromaras A; Mountokalakis T
Endoscopy; 2003 Apr; 35(4):327-32. PubMed ID: 12664390
[TBL] [Abstract][Full Text] [Related]
19. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
[TBL] [Abstract][Full Text] [Related]
20. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage.
Wilcox CM; Shalek KA; Cotsonis G
Arch Intern Med; 1994 Jan; 154(1):42-6. PubMed ID: 8267488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
